Global Antiserum Market Strategic Research Report

Scope of the Report

The global Antiserum market size is predicted to grow from US$ 1,665 million in 2025 to US$ 2,605 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

Antiserum, a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens. Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals. Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.

The Antiserum market belongs to the pharmaceutical industry, and its development is closely related to economic development and people's quality of life. Antiserum is used in the treatment of snake venom, rabies, tetanus, etc. and bacterial detection. The market potential is huge. Policy support and emphasis on food and water safety are the main factors promoting market development.

Product safety risks, high industry barriers, high safety requirements, and stricter market regulation are the main factors hindering market development.

In terms of regional development, at present, the sources of market supply are mainly concentrated in North America. With the technological development and progress of Asian countries, in the future, we can focus on the development trend of Asian regions.

In terms of market competition, due to the higher technical barriers and stricter regulation of biopharmaceuticals, the market competition is relatively mild.

The major global companies of Antiserum include CSL，Merck，BTG，Pfizer，CNBG and etc. The top five vendors held 59% of the market.

In the future, with the continuous development of the market and the increase of new entrants, relevant companies need to fully promote the clinical research and preclinical research of new products, and at the same time continue to research and explore, and strive to achieve technological innovation and breakthroughs in existing products and improve product quality compete with safe, effective, economical and suitable product differentiation, and avoid being eliminated by the continuously developing market.

This report presents a comprehensive overview of the global Antiserum market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Antitoxin Serum
• Antibacterial Serum
• Antiviral Serum
• Others

Segment by players, this report covers

• CSL
• Merck
• BTG
• Pfizer
• CNBG
• Bharat Serums and Vaccines
• Haffkine Bio-Pharmaceutical
• Serum Biotech
• Bio-Rad
• BD
• Vins Bioproducts
• FUJIFILM Wako Pure Chemical Corporation
• SSI Diagnostica
• GD Animal Health

Segment by Application

• Clinical
• Laboratory

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Antiserum market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Clinical, Laboratory evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact